WEBVTT
1
00:00:05.250 --> 00:00:07.410
Exciting times for medical,
2
00:00:07.410 --> 00:00:08.760
and I'd love to hear
3
00:00:08.760 --> 00:00:11.010
about the current state of medical in biopharma.
4
00:00:11.010 --> 00:00:13.500
You know, we are at the cusp and inflection point
5
00:00:13.500 --> 00:00:18.500
of a really transformative moment in clinical research.
6
00:00:18.840 --> 00:00:20.520
Clinical research has really evolved
7
00:00:20.520 --> 00:00:24.510
from an area where we had focused on the evidence,
8
00:00:24.510 --> 00:00:27.540
but we are really now focusing on the delivery of care
9
00:00:27.540 --> 00:00:31.140
and translating that evidence into the clinical setting.
10
00:00:31.140 --> 00:00:34.470
Most of our medical departments are driving
11
00:00:34.470 --> 00:00:36.720
for additional efficiencies.
12
00:00:36.720 --> 00:00:41.720
How do we get better and faster at filling the gaps in data?
13
00:00:42.660 --> 00:00:47.660
How do we get faster and better at bringing in insights
14
00:00:47.790 --> 00:00:52.410
on the gaps in clinical care, the challenges patients face?
15
00:00:52.410 --> 00:00:54.060
And so Sunil, what does that mean for you
16
00:00:54.060 --> 00:00:55.770
for the future of medical then?
17
00:00:55.770 --> 00:00:58.020
Now we have to really understand
18
00:00:58.020 --> 00:01:01.530
what does it take for the medicines to reach patients?
19
00:01:01.530 --> 00:01:05.670
But then how do we better improve the patient experience
20
00:01:05.670 --> 00:01:07.350
with our medicines?
21
00:01:07.350 --> 00:01:09.810
And of that, what excites you the most?
22
00:01:09.810 --> 00:01:13.410
What excites me the most is this evolution in care
23
00:01:13.410 --> 00:01:16.890
where we have gone from evidence-based medicine
24
00:01:16.890 --> 00:01:18.270
to precision medicine,
25
00:01:18.270 --> 00:01:21.960
which is like a biomarker X equals treatment Y
26
00:01:21.960 --> 00:01:24.060
to now personalize medicine,
27
00:01:24.060 --> 00:01:27.510
with the patient, the person, in the center.
28
00:01:27.510 --> 00:01:28.890
Michael, from your perspective then,
29
00:01:28.890 --> 00:01:31.773
what does it mean for biopharma right now?
30
00:01:32.640 --> 00:01:37.640
Biopharma needs to be very thoughtful about the skills
31
00:01:38.190 --> 00:01:40.980
that they're bringing into their medical departments.
32
00:01:40.980 --> 00:01:44.730
The skills of the past may not be, and I would argue,
33
00:01:44.730 --> 00:01:47.190
are not the skills of the future.
34
00:01:47.190 --> 00:01:52.190
We've got a health care system that is burgeoning with data,
35
00:01:53.340 --> 00:01:57.120
but we have not reached the full potential
36
00:01:57.120 --> 00:01:59.580
of understanding that data
37
00:01:59.580 --> 00:02:03.780
and being able to therefore improve outcomes.
38
00:02:03.780 --> 00:02:04.950
The reality is,
39
00:02:04.950 --> 00:02:09.090
whether we, as medical professionals, like it or not,
40
00:02:09.090 --> 00:02:14.090
you know, most people go to Google or trust YouTube,
41
00:02:14.610 --> 00:02:19.590
and so we need to be really present in the digital space
42
00:02:20.580 --> 00:02:23.910
telling our stories, monitoring what's out there,
43
00:02:23.910 --> 00:02:28.230
being comfortable confronting when we see misinformation
44
00:02:28.230 --> 00:02:30.600
and aggressively correcting that.
45
00:02:30.600 --> 00:02:32.100
And Sunil, so for your team,
46
00:02:32.100 --> 00:02:35.535
the AstraZeneca Oncology Business Unit's medical team,
47
00:02:35.535 --> 00:02:39.480
what is your vision then for them in the coming years?
48
00:02:39.480 --> 00:02:41.730
The grand vision is really science to care.
49
00:02:41.730 --> 00:02:44.220
We have three important pillars.
50
00:02:44.220 --> 00:02:46.710
One is how do we transform care today?
51
00:02:46.710 --> 00:02:47.580
And part of that
52
00:02:47.580 --> 00:02:50.310
is how do we better understand the care gaps,
53
00:02:50.310 --> 00:02:51.930
but how do we better understand...
54
00:02:51.930 --> 00:02:55.260
how do we provide the information with the right channels
55
00:02:55.260 --> 00:02:56.790
to the clinical community?
56
00:02:56.790 --> 00:02:59.310
The second is how do we effectively partner?
57
00:02:59.310 --> 00:03:03.420
That partnership has to be with a broader health ecosystem
58
00:03:03.420 --> 00:03:05.100
that includes the clinical team,
59
00:03:05.100 --> 00:03:06.690
includes the health system,
60
00:03:06.690 --> 00:03:08.760
includes health technology,
61
00:03:08.760 --> 00:03:10.440
includes data,
62
00:03:10.440 --> 00:03:13.050
includes patient groups.
63
00:03:13.050 --> 00:03:16.230
And a third pillar is really redefining
64
00:03:16.230 --> 00:03:18.570
what the cancer care paradigm could look like.
65
00:03:18.570 --> 00:03:20.850
Well, very valid points in the sense of also
66
00:03:20.850 --> 00:03:23.760
if you do that, we know there's still a lot of inequity
67
00:03:23.760 --> 00:03:27.210
in terms of cancer access and survival and outcomes.
68
00:03:27.210 --> 00:03:29.160
And I think if you bring that patient voice,
69
00:03:29.160 --> 00:03:31.890
you also bring it in a diverse way,
70
00:03:31.890 --> 00:03:34.680
and you bring all of those perspectives together.
71
00:03:34.680 --> 00:03:36.960
So exciting times for medical
72
00:03:36.960 --> 00:03:38.253
and within pharmaceutical companies.
73
00:03:38.253 --> 00:03:39.690
Also exciting times, I think,
74
00:03:39.690 --> 00:03:42.210
for the medical and the clinical community,
75
00:03:42.210 --> 00:03:46.230
and patients, and anyone involved really in cancer care.
76
00:03:46.230 --> 00:03:47.063
So thank you, both,
77
00:03:47.063 --> 00:03:49.680
for taking the time to share your perspectives.
78
00:03:49.680 --> 00:03:51.270
And I hope that, you know,
79
00:03:51.270 --> 00:03:54.720
we can start to see some continued change
80
00:03:54.720 --> 00:03:57.553
and transformation in cancer care.